Aptose Biosciences Inc.
13F holders, Q1 2024 (March 31)2holders
$1.65avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Aptose Biosciences Inc. in their 13F filings. The largest holders were Annandale Capital, LLC ($44K) and Caldwell Sutter Capital, Inc. ($153).
- Company
- Aptose Biosciences Inc.
- CUSIP
- 03835T200
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 2 holders
| Annandale Capital, LLC | 0.01% | Reduce -64.3% | 26,666 | $44K |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 92 | $153 |
"% of holder's portfolio" is APTOSE BIOSCIENCES INC's weight in each manager's 13F, not the share of Aptose Biosciences Inc. the manager owns.